The Role of Oxidative Stress in Peripheral Neuropathy
- 26 February 2020
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 70 (7) , 1009-1017
Abstract
Peripheral neuropathy (PN) is a common disease affecting about 5% of the general population after the age of 50. Causes of PN are numerous and include genetic, diabetes, alcohol, vitamin deficiencies, and gluten sensitivity among others. This systematic review aimed to study the association between oxidative stress and PN in an attempt to better understand PN pathogenesis. A computer-based, systematic search was conducted on the PubMed database, and ensuing data from included articles was analyzed and discussed in this review. Sixty-nine papers were eligible and were used for this review. Peripheral neuropathy is associated with an increase of reactive oxygen species and a decrease in endogenous antioxidants. Genetic predisposition to oxidative damage may be a factor. Antioxidant treatment is promising regarding treatment. Though further research is necessary to better understand the underlying mechanism, it is evident that oxidative stress is implicated in the pathogenesis of – or is at least systematically present in – PN.Keywords
This publication has 74 references indexed in Scilit:
- P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo ApproachPLOS ONE, 2013
- Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complicationsJournal of Vascular Surgery, 2013
- Obstructive Sleep Apnea and Diabetic Neuropathy: A Novel Association in Patients with Type 2 DiabetesAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Combination of Alpha Lipoic Acid and Superoxide Dismutase Leads to Physiological and Symptomatic Improvements in Diabetic NeuropathyDrugs in R&D, 2012
- Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic PolyneuropathyDiabetes Care, 2011
- Diabetes as a Cause of Clinically Significant Functional Cobalamin DeficiencyDiabetes Care, 2011
- Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitusActa Diabetologica, 2008
- Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axonsExperimental Neurology, 2008
- The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patientsDiabetes & Metabolism, 2006
- Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathyJournal of Neural Transmission, 2002